MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Paroxysmal dyskinesia"

  • 2025 International Congress

    GNAI1-Associated Childhood-Onset Hyperkinetic Movement Disorder: A Case Report

    T. Larsh, A. Espay, D. Gilbert, S. Wu (Cincinnati, USA)

    Objective: To describe the clinical presentation, diagnostic evaluation, and genetic findings in a 7-year-old male with a hyperkinetic movement disorder associated with a novel GNAI1…
  • 2025 International Congress

    Phenotypic Spectrum In Children And Adolescents With Glucose Transporter 1 Deficiency A Multicentric Retrospective Study

    S. Yoganathan, C. Pefaur, V. Gowda, V. Cornejo, V. Quiroz, P. Jain, S. Sharma, L. Guilder, G. Costain, I. Tein, C. Gorodetksy (Toronto, Canada)

    Objective: To describe the spectrum of phenotypes in children and adolescents with biochemically and/or genetically proven Glucose Transporter 1 (GLUT1) deficiency. Background: The phenotypes in…
  • 2025 International Congress

    Development of Gene Panel by Next‐Generation Sequencing Approach for Diagnosis of Paroxysmal Movement Disorders

    PS. Somanna, RS. Sampath, PLK. Kukkle, AK. Kolandaswamy, VKN. Nanjundagowda, RP. P, UR. R, KK. Kotha, PA. Agarwal, SNS. N S, AR. Raina, PKS. Kumar S, GM. Majigoudra (Bangalore, India)

    Objective: To develop a targeted gene panel for Paroxysmal Movement Disorders using Whole Exome Sequencing. Background: Paroxysmal movement disorders (PMDs) are a neurological disorder, characterized…
  • 2025 International Congress

    Phenotypic Spectrum of Movement Disorders in TBC1D24 Gene Variants: A Case Series

    K. Chesky, M. Parnes, M. Hull (Houston, USA)

    Objective: To report the phenotypic spectrum of movement disorders in 5 pediatric patients with TBC1D24 gene variants and provide accompanying video. Background: The TBC1D24 gene…
  • 2025 International Congress

    Novel CUX2 Mutation Identified in Patient with Clinical Paroxysmal Nonkinesigenic Dyskinesia

    C. Cheung, G. Osaki Mark, K. Mackenzie (Elk Grove, USA)

    Objective: In this case, we present a novel mutation in the regulatory region for CUX-2 that is associated with clinical PNKD. Background: Paroxysmal nonkinesigenic dyskinesias…
  • 2025 International Congress

    Paroxysmal Nonkinesigenic Dyskinesia in GLUT1 Deficiency Syndrome: A Rare Manifestation

    A. Medhus, E. Krause (Austin, USA)

    Objective: We describe a rare case of paroxysmal nonkinesigenic dyskinesia (PKND) in a patient with GLUT1 deficiency syndrome (GLUT1-DS). Background: Various movement disorders are a…
  • 2025 International Congress

    Episodic Rocking Movements in a Young Boy.

    A. Singh, J. Singhvi, D. Das, I. Goel (Mohali, India)

    Objective: To present a unique case of a 7-year-old boy with episodic rocking and break-dancing movements from the last 3 years Background: Abnormal episodic movements…
  • 2025 International Congress

    Novel presentation of PRRT2 with paroxysmal dystonia and responsive to carbidopa/levodopa.

    J. Cremin-Endes, M. Walsh, M. Higginson, N. Hack (San Diego, USA)

    Objective: Present a novel case of PRRT2 positive PKD presenting with paroxysmal dystonia that responded to treatment with carbidopa levodopa. First report in the literature.…
  • 2024 International Congress

    A better understanding of Paediatric Paroxysmal Movement Disorders

    S. Harvey, N. Allen, S. Byrne, B. Lynch, N. Mcsweeney, S. Neville, O. O'Mahony, M. O'Regan, D. O'Rourke, E. Reade, D. Webb, M. King, K. Gorman (Dublin, Ireland)

    Objective: To clinically characterise paroxysmal movement disorders (PxMD) and determine prevalence in a paediatric population for the first time. Background: Characterised by episodic involuntary movements,…
  • 2023 International Congress

    Epidemiological, clinical and paraclinical characteristics of paroxysmal dystonia in multiple sclerosis : A study of Tunisian cohort

    M. Adouania, H. Derbali, I. Bedoui, M. Messelmani, M. Ben Mahmoud, N. Ghedamsi, M. Mansour, J. Zaouali, R. Mrissa (Tunis, Tunisia)

    Objective: To describe the specificities of paroxysmal dystonia (PD) in a cohort of Tunisian Multiple Sclerosis (MS). Background: Movements disorders are uncommon in multiple sclerosis.…
  • 1
  • 2
  • 3
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley